Review Article

Murine Models of B-Cell Lymphomas: Promising Tools for Designing Cancer Therapies

Table 1

Spontaneous models of B-cell lymphoma. B-NHL: non-Hodgkin B-cell lymphoma; CLL: chronic lymphocytic leukemia; DLBCL: diffuse large B-cell lymphoma; DTG: double transgenic mice; n.d.: not determined.

NameLymphoma subtype/orginStrain (haplotype)Major reference

B10 H-2a H-4bp/WtsCLLC57Bl/10 (H-2b) [2]
SL/KHPre-B lymphomaSL/KH (H-211) [3]
Eμ-N-mycIndolent B-NHLC57Bl/6 x DBA/2 (H-2b/d) [4]
NFS.V+Marginal zone lymphomaNFS.V+ (H-2sq4) [5]
NMRI/RFB-MuLVn.d.NMRI (H-2q) [6]
B6-l-MYCBurkitt-like lymphomaC57Bl/6 (H-2b) [7]
VavP-Bcl2Follicular lymphomaC57Bl/6 (H-2b) [8]
Lig4/p53 KOPro/Pre-B lymphomaC57Bl/6 × sv129 [9]
Eμ-BRD2DLBCLFVB (H-2q) [10]
Bcl6 Knock inGerminal center, DLBCLC57Bl/6 × sv129 [11]
Bcl6/Myc transgenicPost germinal center, DLBCLC57Bl/6 × sv129 [11]
IL-14aTGxc-Myc TG (DTG)Blastoid variant of mantle-cell lymphomaC57Bl/6 (H-2b) [12]
Myc/BCRHEL/HELBurkitt-like lymphomaC57Bl/6 (H-2b) [13]
Eμ-mycFrom follicular to DLBCL (time dependant)C57Bl/6 × sv129 [14]
RzCD19CreNHL, hepatitis C induced129/Sv (H-2bc); BALB/c (H-2d); C57Bl/6 (H-2b) [15]
UVB inducedMature B-cell lymphomaC57Bl/6 p53+/− (H-2b)[16]